X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global RNA-interference (RNAi) Companies

This report lists the top Global RNA-interference (RNAi) companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global RNA-interference (RNAi) industry.

Home Market Analysis Healthcare Research Biotechnology Research Biotechnology R&D Research Life Science Research Technologies Research RNAi Technology Research RNAi Technology Market Companies

Global RNA-interference (RNAi) Top Companies

  1. Alnylam Pharmaceuticals

  2. Silence Therapeutics PLC

  3. Arrowhead Pharmaceuticals, Inc.

  4. Thermo Fisher Scientific Inc

  5. Dicerna Pharmaceuticals (Novo Nordisk A/S)

*Disclaimer: Top companies sorted in no particular order

Global RNA-interference (RNAi) Market Major Players

Global RNA-interference (RNAi) Market Concentration

Global RNA-interference (RNAi) Market Concentration

Global RNA-interference (RNAi) Company List

                      • Alnylam Pharmaceuticals

                      • Arcturus Therapeutics

                      • Arrowhead Pharmaceuticals, Inc.

                      • Dicerna Pharmaceuticals (Novo Nordisk A/S)

                      • Ionis Pharmaceuticals Inc.

                      • Merck & Co. Inc. (Sigma Aldrich)

                      • Silence Therapeutics PLC

                      • Qiagen NV

                      • Phio Pharmaceuticals Corp.

                      • Thermo Fisher Scientific Inc.


                  Specific to Global RNA-interference (RNAi) Market
                  Need More Details On Market Players And Competitors?
                  Download Sample

                  RNAi Technology Market Report Snapshots

                  RNAi Technology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)